ArticleSurgery today2026
Validation of a nomogram with inflammation-based markers developed to predict difficult laparoscopic cholecystectomy in patients with acute cholecystitis.
Article in Surgery today, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo identify the predictors of difficult laparoscopic cholecystectomy (LC) in patients with acute cholecystitis (AC) and to develop a corresponding nomogram.
methodsIn this retrospective study, we divided patients who underwent LC for acute cholecystitis into a training cohort (223 patients) and a validation cohort (88 patients). We defined difficult LC (DLC) as that resulting in blood loss ≥ 50 mL, operative time ≥ 150 min, or conversion to open surgery (DLC group).
resultsIn the training cohort, the postoperative complication incidence and hospitalization duration were greater in the DLC group than in the non-DLC group (n = 130; 58.3% vs. n = 93; 41.7%, respectively). Multivariate analysis identified male sex, preoperative Glasgow Prognostic Score ≥ 1, neutrophil-to-lymphocyte ratio ≥ 6.75, symptom duration ≥ 72 h, and pericholecystic fat hyperdensity on computed tomography (CT) as independent predictors of DLC. The corresponding nomogram showed good discrimination (area under the curve of 0.806), with 77.55% sensitivity and 72.1% specificity, acceptable calibration, and clinical utility according to decision curve analysis.
conclusionOur nomogram predicts DLC reliably and could be used for preoperative risk assessment and surgical treatment planning.
Indexed as
Identifiers
42406102What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.